Optimi Health Completes Second MDMA Shipment to Australia and Expands 2025 Production Forecast to Support Over 5,000 Patients Globally

3 days ago

Vancouver, British Columbia--(Newsfile Corp. - January 6, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or…

NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

3 days ago

HOUSTON, Jan. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare…

Defence Fortifies Patent Portfolio

3 days ago

Vancouver, British Columbia--(Newsfile Corp. - January 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…

Genflow Biosciences PLC Announces 2024 Highlights

3 days ago

Genflow Biosciences Plc("Genflow" or "the Company")A Look Back at an Exciting 2024 LONDON, UNITED KINGDOM / ACCESSWIRE / January 6,…

Park Systems Corp. Acquires Lyncée Tec SA, Expanding Optical Metrology Portfolio

4 days ago

SUWON, South Korea, Jan. 5, 2025 /PRNewswire/ -- Park Systems Corp. today announced the acquisition of Lyncée Tec SA, a…

Baracoda Unveils BConnect: The World’s First AI-Powered Platform for Rapid IoT Development

4 days ago

Privacy-by-design, low-code platform helps companies bring AI-driven smart devices and gamified apps to market 5 times faster. LAS VEGAS and…

Scryb Announces Non-Brokered Private Placement of Secured Convertible Debentures

4 days ago

Toronto, Ontario--(Newsfile Corp. - January 5, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company"), is pleased to announce its intention…

ITRI Unveils Cutting-Edge Smart Medical Technology at CES 2025

4 days ago

LAS VEGAS, Jan. 5, 2025 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI), Taiwan's largest and one of the world's…

SHOWCASING TOMORROW’S INNOVATORS: LG NOVA RETURNS TO CES 2025

5 days ago

LG NOVA Pushes Forward the Future of Collaboration and Innovation Across Healthtech, AI and Cleantech LAS VEGAS, Jan. 4, 2025…

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

5 days ago

IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical…